Stability of Employment Status Among Patients with Highly Active Relapsing Multiple Sclerosis During the 2-year CLARIFY-MS Study

被引：0
|
作者：
Selmaj, K. [1 ]
Langdon, D. [2 ]
Brochet, B. [3 ]
Havrdova, E. K. [4 ]
Lechner-Scott, J. [5 ,6 ]
Montalban, X. [7 ]
Patti, F. [8 ,9 ]
Piehl, F. [10 ]
Solari, A. [11 ]
Alexandri, N. [12 ]
Nolting, A. [12 ]
Lehn, A. [12 ]
Smyk, A. [12 ]
机构：
[1] Ctr Neurol, Lodz, Poland
[2] Royal Holloway Univ London, Dept Psychol, Egham, Surrey, England
[3] Univ Bordeaux, INSERM U 1215, Bordeaux, France
[4] Charles Univ Prague, Med Fac 1, Prague, Czech Republic
[5] Univ Newcastle, Newcastle, NSW, Australia
[6] John Hunter Hosp, Div Neurol, Newcastle, NSW, Australia
[7] Univ Hosp Vall Hebron, Dept Neurol Neuroimmunol, Ctr Multiple Sclerosis Catalonia Cemcat, Barcelona, Spain
[8] Univ Catania, GF Ingrassia, Dept Med & Surg Sci & Adv Technol, Catania, Italy
[9] Univ Catania, Azienda Osped Univ Policlin G Rodolico San Marco, Catania, Italy
[10] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[11] Fdn IRCCS Ist Neurol Carlo Bes, Unit Neuroepidemiol, Milan, Italy
[12] Healthcare Business Merck KGaA, Darmstadt, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P089
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [31] MRI Outcomes from the Long-term Extension Study of Tolebrutinib in Patients with Relapsing Multiple Sclerosis: 2-Year Results
    Reich, Daniel
    Traboulsee, Anthony
    Syed, Sana
    Xu, Zhixing
    Turner, Timothy
    Arnold, Douglas
    NEUROLOGY, 2023, 100 (17)
  • [32] MRI outcomes from the long-term extension study of tolebrutinib in patients with relapsing multiple sclerosis: 2-year results
    Reich, D. S.
    Traboulsee, A.
    Syed, S.
    Xu, Z.
    Turner, T. J.
    Arnold, D. L.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 334 - 335
  • [33] Durable efficacy of alemtuzumab in CARE-MS II patients with highly active relapsing-remitting multiple sclerosis: 4-year outcomes
    Krieger, S.
    Freedman, M. S.
    Moreau, T.
    Havrdova, E.
    Selmaj, K. W.
    Margolin, D. H.
    Kasten, L.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 573 - 573
  • [34] A Personal Health Record for patients with multiple sclerosis: A 2-year evaluation study
    Aardoom, J.
    van den Berg, L. N.
    Kiveron, L. E.
    van den Akker, M. E.
    Hoitsma, E.
    Chavannes, N. H.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34
  • [35] Effects of 2-year treatment with dimethyl fumarate on cognition and functional impairment in patients with relapsing remitting multiple sclerosis
    Maria Pia Amato
    Benedetta Goretti
    Vincenzo Brescia Morra
    Paolo Gallo
    Mauro Zaffaroni
    Marco Onofrj
    Eleonora Cocco
    Giovanna Borriello
    Valentina Zipoli
    Maria Trojano
    Neurological Sciences, 2020, 41 : 3185 - 3193
  • [36] Quality of life in patients with relapsing-remitting multiple sclerosis treated with immunomodulators: 2-year results in Spain
    Solino, O. Sanchez
    Arroyo, E.
    Grau, C.
    Parra, J. C.
    You, P.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S268 - S268
  • [37] Effects of 2-year treatment with dimethyl fumarate on cognition and functional impairment in patients with relapsing remitting multiple sclerosis
    Amato, Maria Pia
    Goretti, Benedetta
    Morra, Vincenzo Brescia
    Gallo, Paolo
    Zaffaroni, Mauro
    Onofrj, Marco
    Cocco, Eleonora
    Borriello, Giovanna
    Zipoli, Valentina
    Trojano, Maria
    NEUROLOGICAL SCIENCES, 2020, 41 (11) : 3185 - 3193
  • [38] Analysis of Peripheral Blood Mononuclear Cell Phenotypes during Treatment with Fingolimod: A 2-Year Study of a German Cohort of Patients with Relapsing-Remitting Multiple Sclerosis
    Dehmel, Thomas
    Ingenhoven, Kathleen
    Frenken, Pia
    Hermsen, Derik
    Hartung, Hans
    Kieseier, Bernd
    Wamke, Clemens
    NEUROLOGY, 2016, 86
  • [39] Associations between employment status and patient-reported outcome measures in patients with relapsing multiple sclerosis: a longitudinal study
    London, Frederic
    van Pesch, Vincent
    ELSankari, Souraya
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 846 - 846
  • [40] Immunogenicity with peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis: 2-year data from the randomised phase 3, multicentre ADVANCE study in relapsing-remitting multiple sclerosis
    White, J. T.
    Kieseier, B. C.
    Newsome, S. D.
    Zhu, Y.
    Cui, Y.
    Seddighzadeh, A.
    Hung, S.
    Deykin, A.
    Subramanyam, M.
    JOURNAL OF NEUROLOGY, 2014, 261 : S234 - S234
12345